These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37410694)

  • 1. An integrated, systems-wide approach is needed for public-private partnerships to drive genetic innovation in crops.
    Feuillet C; Eversole K
    PLoS Biol; 2023 Jul; 21(7):e3002181. PubMed ID: 37410694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crowd-sourcing delivery system innovation: A public-private solution.
    Agrawal S; Chen C; Tanio CP
    Healthc (Amst); 2015 Mar; 3(1):2-4. PubMed ID: 26179583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The private sector's role in public sector genetically engineered crop projects.
    Potrykus I
    N Biotechnol; 2010 Nov; 27(5):578-81. PubMed ID: 20637908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Achieve Transparency in Public-Private Partnerships Engaged in Hunger and Malnutrition Reduction.
    Eggersdorfer M; Bird JK
    World Rev Nutr Diet; 2016; 115():224-32. PubMed ID: 27198563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A means of improving public health in low- and middle-income countries? Benefits and challenges of international public-private partnerships.
    Kostyak L; Shaw DM; Elger B; Annaheim B
    Public Health; 2017 Aug; 149():120-129. PubMed ID: 28595064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food: Inside the hothouses of industry.
    Gilbert N
    Nature; 2010 Jul; 466(7306):548-51. PubMed ID: 20671688
    [No Abstract]   [Full Text] [Related]  

  • 8. Agricultural biotechnology and smallholder farmers in developing countries.
    Anthony VM; Ferroni M
    Curr Opin Biotechnol; 2012 Apr; 23(2):278-85. PubMed ID: 22155017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Adoption of Genetically Modified (GM) Crops: Challenges for the Public Sector.
    Huesing JE; Andres D; Braverman MP; Burns A; Felsot AS; Harrigan GG; Hellmich RL; Reynolds A; Shelton AM; Jansen van Rijssen W; Morris EJ; Eloff JN
    J Agric Food Chem; 2016 Jan; 64(2):394-402. PubMed ID: 26751159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creative tensions: mutual responsiveness adapted to private sector research and development.
    Sonck M; Asveld L; Landeweerd L; Osseweijer P
    Life Sci Soc Policy; 2017 Sep; 13(1):14. PubMed ID: 28879640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Private firms are told that NHS in England is open for £20bn worth of business.
    Kmietowicz Z
    BMJ; 2012 Sep; 345():e6305. PubMed ID: 22991180
    [No Abstract]   [Full Text] [Related]  

  • 13. Public-private integrated partnerships demonstrate the potential to improve health care access, quality, and efficiency.
    Sekhri N; Feachem R; Ni A
    Health Aff (Millwood); 2011 Aug; 30(8):1498-507. PubMed ID: 21821566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cape Health ups the innovation bar.
    Bateman C
    S Afr Med J; 2011 Dec; 102(1):14. PubMed ID: 22273127
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics and agriculture. Collaborations in rice.
    Fischer KS; Barton J; Khush GS; Leung H; Cantrell R
    Science; 2000 Oct; 290(5490):279-80. PubMed ID: 11183373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organisational innovation and control practices: the case of public-private mix in tuberculosis control in India.
    Engel N; van Lente H
    Sociol Health Illn; 2014 Jul; 36(6):917-31. PubMed ID: 24372316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public-private interactions on health in South Africa: opportunities for scaling up.
    Kula N; Fryatt RJ
    Health Policy Plan; 2014 Aug; 29(5):560-9. PubMed ID: 23962441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 20. Innovation: how do NHS subsidiary companies measure up?
    Williams A
    Health Serv J; 2014 Mar; 123(6391):19-21. PubMed ID: 24956735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.